INSOMNIA is the #8 most commonly reported adverse reaction for METHYLPHENIDATE HYDROCHLORIDE, manufactured by Sandoz Inc. There are 2,092 FDA adverse event reports linking METHYLPHENIDATE HYDROCHLORIDE to INSOMNIA. This represents approximately 2.1% of all 101,957 adverse event reports for this drug.
Patients taking METHYLPHENIDATE HYDROCHLORIDE who experience insomnia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
INSOMNIA2,092 of 101,957 reports
INSOMNIA is a less commonly reported adverse event for METHYLPHENIDATE HYDROCHLORIDE, but still significant enough to appear in the safety profile.
Other Side Effects of METHYLPHENIDATE HYDROCHLORIDE
In addition to insomnia, the following adverse reactions have been reported for METHYLPHENIDATE HYDROCHLORIDE:
Does METHYLPHENIDATE HYDROCHLORIDE cause INSOMNIA?
INSOMNIA has been reported as an adverse event in 2,092 FDA reports for METHYLPHENIDATE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is INSOMNIA with METHYLPHENIDATE HYDROCHLORIDE?
INSOMNIA accounts for approximately 2.1% of all adverse event reports for METHYLPHENIDATE HYDROCHLORIDE, making it a notable side effect.
What should I do if I experience INSOMNIA while taking METHYLPHENIDATE HYDROCHLORIDE?
If you experience insomnia while taking METHYLPHENIDATE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.